Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
63,286,946
-
Share change
-
+7,314,872
-
Total reported value
-
$821,024,064
-
Put/Call ratio
-
29%
-
Price per share
-
$12.97
-
Number of holders
-
250
-
Value change
-
+$94,369,882
-
Number of buys
-
117
-
Number of sells
-
89
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q3 2022
As of 30 Sep 2022,
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by
250 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,286,946 shares.
The largest 10 holders included
Mondrian Investment Partners LTD, MORGAN STANLEY, Clal Insurance Enterprises Holdings Ltd, GOLDMAN SACHS GROUP INC, MACQUARIE GROUP LTD, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., NORTHERN TRUST CORP, FMR LLC, and BRANDES INVESTMENT PARTNERS, LP.
This page lists
254
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.